Kural, Mehmet H. http://orcid.org/0000-0002-3748-4593
Djakbarova, Umidahan
Cakir, Bilal http://orcid.org/0000-0003-4610-0317
Tanaka, Yoshiaki http://orcid.org/0000-0002-2078-9374
Chan, Emily T. http://orcid.org/0000-0001-9510-9049
Arteaga Muniz, Valeria I.
Madraki, Yasaman
Qian, Hong
Park, Jinkyu
Sewanan, Lorenzo R.
Park, In-Hyun http://orcid.org/0000-0001-7748-1293
Niklason, Laura E.
Kural, Comert http://orcid.org/0000-0002-9065-6542
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM127526)
NSF | BIO | Division of Molecular and Cellular Biosciences (1751113)
American Heart Association (17POST33661238)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL148819)
Article History
Received: 8 December 2023
Revised: 4 June 2024
Accepted: 10 June 2024
First Online: 22 June 2024
Competing interests
: L.E.N. is a founder, shareholder, President, and CEO of Humacyte, Inc and serves on Humacyte’s Board of Directors. L.E.N.’s spouse is a shareholder of Humacyte. M.H.K, and H.Q. are shareholders and employees of Humacyte, Inc.
: All animal studies were carried out in accordance with the Yale University’s Institutional Animal Care and Use Committee (IACUC protocol #20218-2021).